adamantane has been researched along with Blood Pressure, High in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (31.58) | 29.6817 |
| 2010's | 12 (63.16) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelrahim, MEA; Elberry, AA; Hussein, RRS; Mohamed Rabea, A; Mohsen, M | 1 |
| Chatterjee, S | 1 |
| Araki, S | 1 |
| Fujisawa, Y; Kobori, H; Kohno, M; Masaki, T; Mori, H; Nakano, D; Nishiyama, A; Ohmori, K; Rafiq, K; Rahman, A; Sufiun, A | 1 |
| Bhullar, H; Carbonari, DM; Cardillo, S; Esposito, DB; Gallagher, AM; Haynes, K; Hennessy, S; Holick, CN; Lo Re, V; Newcomb, CW; Nezamzadeh, MS; Roy, JA; Saine, ME; Strom, BL | 1 |
| Kitayama, T; Kunori, S; Myojo, K; Sakai, M; Uchii, M | 1 |
| Cosenso-Martin, LN; Giollo-Junior, LT; Vilela-Martin, JF | 1 |
| Kimoto, N; Kitayama, T; Kunori, S; Sakai, M; Uchii, M | 1 |
| Chen, CC; Huang, LT; Lin, YJ; Lu, PC; Sheen, JM; Tain, YL; Tiao, MM; Tsai, CC; Yu, HR | 1 |
| Carroll, MA; Chander, PN; Falck, JR; Li, J; Sangras, B; Stier, CT | 1 |
| Anandan, SK; Chen, D; Gless, RD; MacIntyre, DE; Rubanyi, GM; Vincelette, J; Wang, YX; Webb, HK; Zhang, LN | 1 |
| Aavula, BR; Anandan, SK; Cases, S; Chen, D; Cheng, Y; Do, ZN; Gless, R; Hammock, BD; Jones, PD; MacIntyre, DE; Mehra, U; Patel, DV; Sabry, J; Tran, V; Vincelette, J; Wang, YX; Waszczuk, J; Webb, HK; Whitcomb, R; White, K; Wong, KR; Zhang, LN | 1 |
| Braam, B; Hammock, BD; Joles, JA; Koeners, MP; Morisseau, C; Sepúlveda, RL; Ulu, A; Wesseling, S | 1 |
| Ciszewski, A; Corbalan, JJ; Jacob, RF; Kubant, R; Malinski, T; Mason, RP | 1 |
| Cha, SH; Endou, H; Fujita, T; Hayashi, I; Higashihara, M; Majima, M; Yamanaka, M | 1 |
| Brandes, RP; Busse, R; Fleming, I; Hammock, BD; Jung, O; Kim, IH; Schmidt, R; Schweda, F | 1 |
| Hammock, BD; Imig, JD; Kim, IH; Newman, JW; Olearczyk, JJ; Pollock, DM; Watanabe, T; Zaharis, CZ; Zhao, X | 1 |
| Dorrance, AM; Hammock, BD; Imig, JD; Newman, JW; Pollock, DM; Rupp, N | 1 |
| Hammock, BD; Imig, JD; Kim, IH; Luria, A; Mitchell, BC; Newman, JW; Olearczyk, JJ; Quigley, JE; Yamamoto, T | 1 |
1 review(s) available for adamantane and Blood Pressure, High
| Article | Year |
|---|---|
[Diabetic nephropathy].
Topics: Adamantane; Aged; Aged, 80 and over; Aging; Albuminuria; Antihypertensive Agents; Diabetic Nephropathies; Dipeptidyl-Peptidase IV Inhibitors; Disease Progression; Humans; Hypertension; Hypoglycemia; Hypoglycemic Agents; Kidney; Nitriles; Pyrrolidines; Renal Dialysis; Sulfonylurea Compounds; Vildagliptin | 2013 |
18 other study(ies) available for adamantane and Blood Pressure, High
| Article | Year |
|---|---|
Saxagliptin and vildagliptin lowered albuminuria in patients with diabetes and hypertension independent on glycaemic control.
Topics: Adamantane; Albuminuria; Animals; Diabetes Mellitus, Type 2; Dipeptides; Glycemic Control; Humans; Hypertension; Rats; Vildagliptin | 2021 |
Glycemic effects of vildagliptin and metformin combination therapy in Indian patients with type 2 diabetes: an observational study.
Topics: Adamantane; Blood Glucose; Comorbidity; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Administration Schedule; Drug Therapy, Combination; Fasting; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypertension; Hypoglycemic Agents; India; Metformin; Nitriles; Obesity; Postprandial Period; Pyrrolidines; Retrospective Studies; Treatment Outcome; Vildagliptin | 2014 |
Effect of dipeptidyl peptidase-4 inhibition on circadian blood pressure during the development of salt-dependent hypertension in rats.
Topics: Adamantane; Animals; Antihypertensive Agents; Arterial Pressure; Blood Pressure; Circadian Rhythm; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Glucagon-Like Peptide 1; Heart Rate; Hypertension; Injections, Intraventricular; Male; Nitriles; Pyrrolidines; Rats; Rats, Inbred Dahl; Sodium; Sodium Chloride, Dietary; Telemetry; Vildagliptin | 2015 |
Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugs.
Topics: Adamantane; Administration, Oral; Adolescent; Adult; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Female; Glycated Hemoglobin; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Male; Middle Aged; Practice Patterns, Physicians'; United Kingdom; United States; Young Adult | 2015 |
Critical role of renal dipeptidyl peptidase-4 in ameliorating kidney injury induced by saxagliptin in Dahl salt-sensitive hypertensive rats.
Topics: Adamantane; Albuminuria; Animals; Blood Glucose; Blood Pressure; Cytoprotection; Dipeptides; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension; Kidney Diseases; Kidney Glomerulus; Male; Rats, Inbred Dahl; Sitagliptin Phosphate | 2015 |
DPP-4 Inhibitor Reduces Central Blood Pressure in a Diabetic and Hypertensive Patient: A Case Report.
Topics: Adamantane; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Humans; Hypertension; Hypoglycemic Agents; Middle Aged; Nitriles; Pyrrolidines; Vascular Stiffness; Vildagliptin | 2015 |
Glucose-independent renoprotective mechanisms of the tissue dipeptidyl peptidase-4 inhibitor, saxagliptin, in Dahl salt-sensitive hypertensive rats.
Topics: Adamantane; Animals; Blood Glucose; Blood Pressure; Creatinine; Cytoprotection; Dipeptides; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Fibrosis; Gene Expression Regulation; Hypertension; Kidney; Kidney Glomerulus; Kidney Tubules; Male; Myocardium; Organ Size; Rats; Rats, Inbred Dahl; Sodium | 2016 |
Early postnatal treatment with soluble epoxide hydrolase inhibitor or 15-deoxy-Δ(12,14)-prostagandin J2 prevents prenatal dexamethasone and postnatal high saturated fat diet induced programmed hypertension in adult rat offspring.
Topics: Adamantane; Angiotensin-Converting Enzyme 2; Animals; Arachidonic Acid; Dexamethasone; Diet, High-Fat; Epoxide Hydrolases; Female; Humans; Hypertension; Lauric Acids; Nitric Oxide; Peptidyl-Dipeptidase A; Pregnancy; Prenatal Exposure Delayed Effects; Prostaglandin D2; Rats; Receptor, Angiotensin, Type 2 | 2016 |
Soluble epoxide hydrolase inhibitor, AUDA, prevents early salt-sensitive hypertension.
Topics: Adamantane; Animals; Eicosanoic Acids; Enzyme Inhibitors; Epithelial Sodium Channels; Epoxide Hydrolases; Hypertension; Lauric Acids; Male; Rats; Rats, Inbred SHR; Sodium Chloride; Stroke | 2008 |
Inhibition of soluble epoxide hydrolase attenuates endothelial dysfunction in animal models of diabetes, obesity and hypertension.
Topics: Adamantane; Administration, Oral; Animals; Aorta; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Endothelium, Vascular; Epoxide Hydrolases; Hypertension; Male; Mesenteric Arteries; Mice; Mice, Inbred C57BL; Niacinamide; Obesity; Phenylurea Compounds; Rats; Rats, Sprague-Dawley; Urea; Vasodilation | 2011 |
1-(1-acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemia.
Topics: Adamantane; Administration, Oral; Angiotensin II; Animals; Antihypertensive Agents; Blood Glucose; Disease Models, Animal; Enzyme Inhibitors; Epoxide Hydrolases; Hypertension; Insulin Resistance; Mice; Obesity; Rats; Urea | 2011 |
Soluble epoxide hydrolase in the generation and maintenance of high blood pressure in spontaneously hypertensive rats.
Topics: Adamantane; Age Factors; Animals; Enzyme Inhibitors; Epoxide Hydrolases; Female; Gestational Age; Hypertension; Lauric Acids; Male; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; Solubility | 2011 |
Dipeptidyl peptidase-4 inhibition with saxagliptin enhanced nitric oxide release and reduced blood pressure and sICAM-1 levels in hypertensive rats.
Topics: Adamantane; Animals; Aorta; Blood Pressure; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Endothelium, Vascular; Glucose Tolerance Test; Hypertension; Insulin; Intercellular Adhesion Molecule-1; Kidney Glomerulus; Male; Nitric Oxide; Peroxynitrous Acid; Rats; Rats, Zucker | 2012 |
Potassium-induced increase in renal kallikrein secretion is attenuated in dissected renal connecting tubules of young spontaneously hypertensive rats.
Topics: Adamantane; Animals; Dose-Response Relationship, Drug; Hypertension; In Vitro Techniques; Kallikrein-Kinin System; Kallikreins; Kidney Tubules; Male; Morpholines; Potassium Channel Blockers; Potassium Chloride; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley | 2002 |
Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension.
Topics: Adamantane; Amides; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Diuresis; Epoxide Hydrolases; Hydroxyeicosatetraenoic Acids; Hypertension; In Vitro Techniques; Lauric Acids; Male; Mice; Mice, Inbred Strains; Natriuresis; Renal Circulation; Solubility; Sulfones; Vasoconstrictor Agents; Vasodilation | 2005 |
An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension.
Topics: Adamantane; Albuminuria; Angiotensins; Animals; Blood Pressure; Cell Count; Epoxide Hydrolases; Hypertension; Kidney; Kidney Diseases; Lauric Acids; Macrophages; Male; Rats; Rats, Sprague-Dawley; Sodium Chloride | 2005 |
An epoxide hydrolase inhibitor, 12-(3-adamantan-1-yl-ureido)dodecanoic acid (AUDA), reduces ischemic cerebral infarct size in stroke-prone spontaneously hypertensive rats.
Topics: Adamantane; Animals; Brain Ischemia; Cerebral Infarction; Enzyme Inhibitors; Epoxide Hydrolases; Epoxy Compounds; Hypertension; Lauric Acids; Male; Neuroprotective Agents; Rats; Rats, Inbred SHR | 2005 |
Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats.
Topics: Adamantane; Animals; Antihypertensive Agents; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Hypertension; Insulin; Lauric Acids; Lipids; Male; NF-kappa B; Rats; Rats, Inbred Strains | 2009 |